Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

TM Oberon UK Core Fund 2026 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (TM Oberon UK Core Fund)

Primary Source Intelligence • Q3 2026 Letter Analysis

TM Oberon UK Core Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, TM Oberon UK Core Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+0.7%

YTD+12.2%

Positioning StanceBULLISH

Market CapAll Cap

GeographyEurope

Digest Analysis

Quick Take

"UK equities trade at substantial discounts to international peers, creating compelling upside across cash-generative mid- and small-cap businesses with distinct self-help catalysts."

Executive Summary

TM Oberon UK Core Fund (B Accumulation share class) returned 0.7% net of fees for the third quarter of 2026, lagging the IA UK All Companies Sector return of 3.2%. Year to date, the strategy delivered 12.2% net of fees compared to 8.5% for the peer group benchmark. Portfolio capital remained diversified across 38 holdings with a 2.9% cash weighting, divided across companies capitalised above £5bn (22.3%), £500m to £5bn (41.7%), and under £500m including cash (36.0%). Macroeconomic headwinds resurfaced early in the quarter as Middle East hostilities disrupted commercial shipping in the Strait of Hormuz, driving Brent crude over $100 per barrel and lifting domestic inflation to 3.1%. Despite the Bank of England holding benchmark rates at 3.75% amidst hawkish dissent, UK mid- and small-cap indices outperformed the FTSE 100 for a second straight quarter. The manager highlights significant valuation dislocations across UK equities relative to global peers, further catalyzed by prospective domestic housing policy. Quarterly gains were driven by operational turnarounds and cash returns in Victrex, Xaar, and Harbour Energy, which were dampened by sharp markdowns in Acceler8 Ventures, Ondine Biomedical, and BATM Advanced Communications. Portfolio activity included establishing a new position in vehicle distributor Inchcape and taking part in an equity placing for Oxford BioDynamics, funded by a profitable takeover exit in DCC at a 24% premium and closing out Incanthera.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

65%

CautiousHigh

Moderate (65%)

The portfolio maintains moderate concentration across 38 holdings with top positions sized between 3.6% and 5.5% of fund assets. The manager demonstrates clear, detailed rationales for high-conviction positions such as Victrex, Xaar, and Harbour Energy while participating in corporate equity placings.

Growth Outlook

75%

BearishBullish

Bullish (75%)

The outlook on UK equity valuations is distinctly positive, highlighting that the broader market trades at persistent discounts relative to international peers while M&A buyers and mid-cap re-ratings begin to unlock value.

Risk Appetite

75%

DefensiveAggressive

Aggressive (75%)

The fund maintains a risk-tolerant posture with a low 2.9% cash buffer and an aggressive 77.7% collective weighting allocated to mid-, small-, and micro-cap equities.

Capital Deployment

60%

De-riskingDeploying

Net Neutral (60%)

Capital deployment remained balanced, recycling proceeds from the private equity takeover of DCC into a new core holding in Inchcape and an equity placing in Oxford BioDynamics while preserving low cash levels at 2.9%.

Forward Guidance

70%

CautiousExpansionary

Expansionary (70%)

The manager remains oriented toward deploying into undervalued recovery situations, recently opening a new position in Inchcape and subscribing to an equity placing for Oxford BioDynamics while recycling capital out of acquired names.

Language Signal

75%

BearishBullish

Bullish (75%)

Letter commentary heavily leans toward constructive terminology including substantial discount, significant upside, mispriced, operational progress, and catalysts, despite acknowledging macroeconomic volatility from Middle Eastern energy disruptions.

Perceived Risk

60%

Low RiskElevated

Moderate Risk (60%)

Macroeconomic threats are explicitly noted, specifically Strait of Hormuz conflict escalations driving crude over $100 per barrel, UK inflation re-accelerating to 3.1%, and hawkish voting patterns at the Bank of England.

Opportunity Density

80%

ScarceAbundant

Abundant (80%)

Investment opportunities are identified across a wide spectrum of market capitalisations and sectors, from industrial polymers and oil producers to cyber defense turnarounds and consumer automotive franchises.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The fund's objective explicitly mandates a 5-year plus horizon, and portfolio commentary repeatedly focuses on multi-year operational turnarounds and long-term value realization.